Chemed (CHE) Non-Current Deferred Tax Liability (2009 - 2026)

Chemed has reported Non-Current Deferred Tax Liability for 18 years, with the latest figure at $15.0 million in Q2 2026.

• Non-Current Deferred Tax Liability for Q2 2026 came in at $15.0 million, up 18.48% year-over-year; the trailing twelve-month figure through Jun 2026 was $15.0 million (up 18.48% YoY), and the FY2025 annual result was $19.3 million, down 25.56% from the prior year.
• Non-Current Deferred Tax Liability grew to $15.0 million in Q2 2026, from $14.6 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $38.6 million in Q4 2022 and troughed at $9.7 million in Q3 2025.
• A 5-year average of $24.2 million and a median of $25.4 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• The widest annual swing landed in 2023, when Non-Current Deferred Tax Liability jumped 85.09%; it then tumbled 65.5% in 2025.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $38.6 million in 2022, then slipped by 21.47% to $30.3 million in 2023, then slipped by 14.43% to $25.9 million in 2024, then dropped by 25.56% to $19.3 million in 2025, then retreated by 22.07% to $15.0 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $15.0 million in Q2 2026, $14.6 million in Q1 2026, and $19.3 million in Q4 2025.